Non-Small Cell Lung Cancer Market By System Type, By End User, By Region, Industry Analysis and Forecast, 2022 to 2032

 


The global non-small cell lung cancer market had a market value of US$ 10 billion in 2023 and is predicted to reach a market value of US$ 20 billion by 2033, growing at a CAGR of 7.2% from 2023 to 2033. Its rapid expansion can be attributed to an increasing patient population, the projected introduction of many treatments, and greater investment in NSCLC research and development by market participants.

Non-small cell lung cancer, one of the most common kinds of lung cancer, reduces the lungs’ ability to provide oxygen to the blood. Non-small cell lung cancer accounts for 80-85% of all lung cancer cases worldwide. The causes are passive smoking, active smoking, consuming polluted water, and being exposed to air pollution. It can, however, be treated with a variety of medicines such as immunotherapy, targeted therapy, and others.

Request Sample Copy of Report @
https://www.futuremarketinsights.com/reports/sample/rep-gb-16143

The two primary causes of non-small cell lung cancer are excessive tobacco intake and active participation in passive smoking. Long-term air pollution exposure promotes the development of non-small cell lung cancer. However, the existence of large firms, as well as the entry of new essential players, will result in excessive market rivalry. This will decrease the rate of expansion of the lung cancer treatments market. The high expense of therapy or treatment will limit the scope of expansion even further. Because of the prevalence of advanced healthcare infrastructure, greater research and development capabilities by pharmaceutical firms, and quick adoption of new and better healthcare technology, North America leads the non-small cell lung cancer market. Asia-Pacific, on the other hand, is expected to have the greatest growth rate throughout the projection period due to increased healthcare infrastructure spending, increasing prevalence of non-small cell lung cancer, and a growing senior population sensitive to cancer.

Key Takeaways from the Market Study

  • FMI projects the global non-small cell lung cancer market to expand at a 7.2% value CAGR by 2033
  • The global non-small cell lung cancer market is estimated at a market value of US$ 10 Billion
  • The global non-small cell lung cancer market is expected to garner a market value of US$ 20 Billion
  • North America is forecast to be the most lucrative for non-small cell lung cancer market growth.
  • As per Future Market Insights, the Asia Pacific is expected to grow at a CAGR of 6.7% during the assessment period 2023-2033.
  • Europe is expected to grow at a CAGR of 7% during the assessment period 2023 to 2033.
  • The chemotherapy segment is expected to hold the largest market share for non-small cell lung cancer in the forecast period 2023 to 2033.

Ask an Analyst @
 https://www.futuremarketinsights.com/ask-question/rep-gb-16143

 “Rising investment in research & development efforts by the key players will fuel market expansion even more,” says an analyst at FMI

Market Competition

Key players in the non-small cell lung cancer market are F. Hoffmann-La Roche Ltd., Bristol-Myers Squibb Company, Pfizer Inc., AstraZeneca, Novartis AG, Eli Lilly and Company, Merck & Co., Inc., Boehringer Ingelheim International GmbH, Sanofi, Astellas Pharma Inc.

Recent Developments:

  • In December 2022, Pluvicto®, a targeted radioligand treatment, has been authorised by the European Commission (EC), according to Novartis. Pluvicto® is licensed for the treatment of adult patients with prostate-specific membrane antigen (PSMA)-positive metastatic castration-resistant prostate cancer in conjunction with androgen deprivation therapy (ADT) with or without androgen receptor (AR) pathway inhibition (mCRPC). AR pathway inhibitor and taxane-based chemotherapy were used to treat these individuals.

More Insights Available

Future Market Insights, in its new offering, presents an unbiased analysis of the global non-small cell lung cancer market, presenting historical analysis from 2018 to 2022 and forecast statistics for the period of 2023 to 2033.

Buy Complete Report @
 https://www.futuremarketinsights.com/checkout/16143

Key Segments Profiled in the Non-Small Cell Lung Cancer Market Industry Survey

Non-Small Cell Lung Cancer Market by Cancer Type:

  • Squamous Cell Carcinoma
  • Adenocarcinoma
  • Large-cell Carcinoma

Non-Small Cell Lung Cancer Market by Treatment:

  • Chemotherapy
  • Targeted Therapy
  • Immunotherapy

About the Healthcare at Future Market Insights

The healthcare team at Future Market Insights offers expert analysis, time efficient research, and strategic recommendations with an objective to provide authentic insights and accurate results to help clients worldwide. With a repertoire of over 100+ reports and 1 million+ data points, the team has been analyzing the industry lucidly in 50+ countries for over a decade. The team provides a brief analysis on key trends including competitive landscape, profit margin, and research development efforts.

Comments

Post a Comment

Popular posts from this blog

Cardboard Flask Market Insights By Type, Industry, Application & End-User | FMI

 Beverage industry which is growing continuously has led to developments and innovations in the cardboard flask market. Countries that have high consumption of tea and coffee such as the USA, United Kingdom, China, Japan & India might impact the demand for cardboard flask. Cardboard flasks might not be predominant when it comes to the sale of these hot beverages in the brick and mortar store but E-commerce has hiked the demand for cardboard flask. The convenience and ease of ordering the hot beverages at their workplace and homes with advent of digitalization in developing countries such as India and China is likely to augment the demand for the cardboard flask market. Compared to its counterpart which is a traditional flask which were used by the brand owners to deliver the beverage to its customers, the cardboard flask provides more pros since its cuts down the cost of collecting and cleaning them. Thus, this is likely to positively impact the growth of the cardboard flask market
Read more

Veterinary Ultrasound Scanners Market Size, Share, Industry Analysis, Future Growth, Segmentation, Competitive Landscape, Trends and Forecast 2022 to 2028

  Future Market Insights (FMI) offers a 10-year forecast on the global  veterinary ultrasound scanners market.  The primary objective of the report is to offer updates and information related to market opportunities in the veterinary ultrasound scanners market. By the end of 2028, the market for veterinary ultrasound scanners, which is presently valued at US$ 190 Million, is expected to have grown at a CAGR of 4% and be worth US$ 240 Million. Future Market Insights foresees a comparison and review study of the dynamics of the market for veterinary ultrasound scanners, which is primarily influenced by a variety of industry aspects as well as a few distinct influences on therapeutic views that foster industry innovation. The market is significantly impacted by industry, macroeconomic, and inventive aspects. Market changes include wireless streaming on IBEX® PRO and LITE models and the creation of goods like the OsiriX® viewer for dogs, which enables precise and repeatable. Visit Fo
Read more

Companion Diagnostics Market Current and Future Trends, Leading Players, Industry Segments and Regional Forecast to 2022 to 2032 | Says FMI Analyst

 The global  Companion Diagnostics Market  is projected CAGR of 7.1% during the forecast period, the global companion diagnostics market is expected to generate sales of around US$ 5152.064939 million by 2032, up from US$ 2452.653722 million in 2022. Companion diagnostics is used to determine who would benefit from treatment, and the demand for it is increasing as it helps to identify if someone cannot be cured, but can also be harmed by the use of a specific drug used to treat their ailment. Furthermore, the growth of the companion diagnostics market is being propelled by technological advancements, which have brought about significant changes in the overall method of disease treatment. Request a sample of this report @ https://www.futuremarketinsights.com/reports/sample/rep-gb-1255 Companion Diagnostics Market: Segmentation Valuable information covered in the FMI’s Companion Diagnostics market report has been segregated into key segments and sub-segments. By Application
Read more